Can Panax notoginseng in Benyuan Qingyangwei Gan Wei Tablet protect liver? What are the main ingredients?

Panax notoginseng has the reputation of "gold will not change" and "southern magic grass", and belongs to the same family as ginseng and American ginseng. "Compendium of Materia Medica" records: "Ginseng supplements qi first, and Sanqi supplements blood first. The taste is the same, and the merits are equivalent, so it is called Ginseng Sanqi, which is a treasure in Chinese medicine. "

Panax notoginseng has a wide range of pharmacological effects, including saponins, flavonoids, polysaccharides, alcohols and notoginsenoside. Panax notoginseng saponins, Panax notoginseng saponins? Ketone and Panax notoginseng polysaccharide have protective effects on immune liver injury in different degrees. Modern medical research has proved that the content of panax notoginseng saponins is 10%, and ginseng is 3.80%. Therefore, among the members of the ginseng family, the content of saponins, effective medicinal components and active substances of Panax notoginseng are relatively high, so modern Chinese medicine pharmacologists call it "the king of ginseng".

Panax notoginseng, the core raw material of Wei Yan Gan Wei tablets, is a national food and health product, which adopts one of the world's advanced patented technologies of Panax notoginseng and is a GAP planting base certified by the State Administration of Pharmaceutical Products. After 7-9 years of natural growth without artificial intervention, the content of 24.55438+0% total saponins is much higher than the national pharmacopoeia standard, and it belongs to the first-class product in Panax notoginseng.

In addition, there are Ganoderma lucidum and Phyllanthus emblica in Ye Wei brand Gan Wei films, both of which are valuable ingredients for nourishing the liver. Ganoderma lucidum has a good function of protecting and nourishing liver, and can treat the increase of transaminase caused by various hepatitis. The aqueous extract of Phyllanthus emblica can inhibit the production of lipid peroxide (LPO) in hepatocytes in vitro and alleviate the acute and chronic hepatotoxicity caused by CCl 4.